Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Surgical Devices
procept-biorobotics.com

See what CB Insights has to offer

Founded Year

2009

Stage

IPO | IPO

Total Raised

$348.84M

Date of IPO

9/15/2021

About PROCEPT BioRobotics

PROCEPT BioRobotics (NASDAQ: PRCT) is a clinical-stage medical device company based in Silicon Valley. The company has developed a surgical product for transurethral resection of prostate tissue – The AquaBeam – and other treatment and diagnostic applications. The AquaBeam is as an intelligent image-guided tissue removal system, which utilizes proprietary heat-free high-velocity waterjet technology to resect and remove a predetermined volume of tissue with precise and automated incisions conforming to the shape of the prostate.

PROCEPT BioRobotics Headquarter Location

900 Island Drive Suite 210

Redwood City, California, 94065,

United States

650-232-7200

Latest PROCEPT BioRobotics News

PROCEPT BioRobotics Corporation : Goldman Sachs bleibt neutral

Oct 11, 2021

(marketscreener.com) Die Untersuchungen von Goldman Sachs bestätigen seinen Rat und halten an seiner neutralen Meinung über den Bestand fest.https://de.marketscreener.com/kurs/aktie/PROCEPT-BIOROBOTICS-CORPO-126986326/news/PROCEPT-BioRobotics-Corporation-Goldman-Sachs-bleibt-neutral-36653524/?utm_medium=RSS&utm_content=20211011

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing PROCEPT BioRobotics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

PROCEPT BioRobotics is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

11,378 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Digital Health

11,220 items

Companies leveraging digital technology for healthcare, consumer health, clinical research, and life science (e.g. biopharma, medtech) applications.

PROCEPT BioRobotics Patents

PROCEPT BioRobotics has filed 41 patents.

The 3 most popular patent topics include:

  • Digestive system surgery
  • Medical equipment
  • Surgery
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/27/2020

8/24/2021

Surgery, Robotic manipulators, Medical equipment, Radiation therapy, Surgical removal procedures

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/27/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/24/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Surgery, Robotic manipulators, Medical equipment, Radiation therapy, Surgical removal procedures

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

PROCEPT BioRobotics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

PROCEPT BioRobotics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.